App-Quantinova.ai

Both Mineralocorticoid Receptor and Angiotensin II type 1 Receptors in the Subfornical Organ Mediate Angiotensin II Induced Reactive Oxygen Species (ROS) in Brain Angiotensinergic Pathways

Roselyn White - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

Angiotensin II

Circulating Second-messenger Glycerophosphocholines and Cardiovascular Risk Factors in a Population-based Sample of Adolescents

Michal Abrahamowicz - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

False Positive Stress Testing: Does Endothelial Vascular Dysfunction Explain ST-Segment Depression in the Absence of Clinical Coronary Artery Disease in Women?

Shilpa Agrawal - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronary Artery Disease

N/A

Angiotensin II-Mediated Cardiac Remodeling in cChAT Mice

Geisa C Tezini - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypertrophic cardiomyopathy

Angiotensin II

Low Diastolic Blood Pressure and Risk of Stroke in the Setting of Intensive Systolic Blood Pressure Control: The SPS3 study

Carmen Peralta - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Physicians are More Prone to Causing White Coat Hypertension than Nurses or Cardiovascular Technicians: An Observational Study

Arjun K Pandey - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

White coat hypertension

N/A

Employing the DASH Diet to Treat Non-dippers: A Two-month Intervention Study

Arjun K Pandey - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Congestive heart failure

N/A

A Maternal High Salt Diet During Pregnancy and Lactation Affects Offspring Cardiac Function

Kana Maruyama - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

Regular Exercise Improves the Lipoprotein Subclass Profile: Meta-Analysis of 10 Exercise Training Intervention Groups

Tuomo Rankinen - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

The CHANGE Study: Comprehensive Primary Pulmonary Hypertension Assessment & Nutritional manaGEment

Arjun K Pandey - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Pulmonary arterial hypertension

N/A

Central Mechanisms Mediating Angiotensin II-Salt Hypertension in Rats

Hong-Wei Wang - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

Spironolactone

Impact of a 12-Weeks Supervised Physical Activity Program After Bariatric Surgery on Cardiorespiratory Capacity; A Randomized Study

Auclair Audrey - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Tuberculosis

N/A

Central Nervous System Control of Plasma Aldosterone and Endogenous Ouabain in Angiotensin II-Salt Hypertension

Hong-Wei Wang - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

Spironolactone

25-OH Vitamin D concentration and All-Cause Mortality Following Coronary Catheterization in Alberta, Canada.

Michael Gerling - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Coronary Artery Disease

Ergocalciferol

Periodontal Bacteria, Prevalent Prediabetes and Plasma Glucose Progression: The Oral Infections, Glucose Intolerance and Insulin Resistance Study (ORIGINS)

David R Jacobs JR - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Prediabetes

N/A

Mendelian Randomization Supports Causality Between Maternal Hyperglycemia and Fetal Metabolic Programming by Leptin Epigenetic Modulation

Catherine Allard - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Gestational Diabetes

N/A

Matrix Metalloproteinase 2 Plays An Important Role In Angiotensin Ii-induced Vascular Injury Mediated In Part Through Epidermal Growth Factor Receptor Activation In Vascular Smooth Muscle Cells

Muhammad Oneeb Rehman Mian - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

Angiotensin II

Angiotensin II-induced Hypertension And Vascular Injury Is Mediated By Gamma/delta T Cells

Muhammad Oneeb Rehman Mian - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

Angiotensin II

Non-coding Rna Regulation Of Gene Expression In Angiotensin Ii-induced Vascular Damage

Tlili Barhoumi - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypertension

Angiotensin II

Quality of CT Perfusion Imaging Thresholds for Infarct and Penumbra in the Acute Ischemic Stroke Setting: An Updated Systematic Review

Jonathan Dykeman - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Filters

28841 Abstracts